You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Suppliers and packagers for generic pharmaceutical drug: COPPER HISTIDINATE


✉ Email this page to a colleague

« Back to Dashboard


COPPER HISTIDINATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Sentynl Theraps Inc ZYCUBO copper histidinate POWDER;SUBCUTANEOUS 211241 NDA Sentynl Therapeutics, Inc. 42358-329-01 1 VIAL, GLASS in 1 CARTON (42358-329-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS 2026-01-12
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for Copper Histidinate

Last updated: March 8, 2026

Copper Histidinate is a specialized supplement administered in clinical and research settings, often associated with copper supplementation therapies. The market for this compound is niche, with suppliers primarily focused on fine chemical manufacturing, pharmaceutical-grade ingredient production, and custom synthesis firms.

Major Suppliers

Company Name Location Capabilities Product Certification Notes
Thermo Fisher Scientific United States Custom synthesis, GMP manufacturing FDA-approved, cGMP Supplies laboratory-grade and pharmaceutical-grade copper histidinate through custom synthesis services.
Spectrum Chemical United States Bulk chemicals, specialty ingredients USP, EP, FCC standards Offers commercial quantities of copper salts, including histidinate derivatives.
Alfa Aesar (Thermo Fisher) United Kingdom Fine chemicals, research compounds USP, EP standards Provides high-purity copper compounds, including histidinate compounds via custom order.
Toronto Research Chemicals Canada Specialty chemicals Analytical and chemical-grade Supplies copper salts, with custom synthesis options for histidinate derivatives.
Hangzhou J&K Chemical China Fine chemicals, custom synthesis Various quality certifications Offers zinc, copper histidinate compounds mainly for research and development purposes.

Key Considerations for Suppliers

  • Purity Standards: Vendors should supply copper histidinate conforming to USP, EP, or GMP standards if intended for pharmaceutical use.
  • Custom Synthesis: Niche compounds often require custom synthesis capabilities. Verified suppliers offer tailored manufacturing in small or large batches.
  • Regulatory Approvals: Check for product documentation including safety data sheets, certificates of analysis, and pharmacopoeia compliance for pharmaceutical applications.
  • Lead Times: Synthesis and delivery times vary from product to product. Large suppliers typically provide faster turnaround times.
  • Pricing: Cost depends on purity, quantity, and certification level. Bulk orders usually attract discounts.

Market Trends

  • The demand for copper-based supplements, including histidinate derivatives, correlates with growth in trace element supplementation in clinical nutrition.
  • Suppliers with GMP and FDA-approved processes are preferred for manufacturing pharmaceutical-grade products.
  • China remains a leading exporter of research-grade copper salts, with emerging presence in GMP-certified manufacturing.

Sourcing Insights

  • Pharmaceutical-Grade Suppliers: Focus on firms with ISO certifications, GMP compliance, and documented batch records.
  • Research-Grade Suppliers: Suitable for R&D purposes; they offer lower cost but lack regulatory assurances.
  • Custom Synthesis Providers: Offer tailored production for both research and pharmaceutical stages, particularly for low-volume or highly pure requirements.

Considerations for Procurement

  • Verify supplier certifications and batch documentation.
  • Confirm the product’s conforming standards to intended use.
  • Evaluate the supplier’s capacity for large-volume orders if needed.
  • Confirm lead times and shipping options.

Key Takeaways

Copper Histidinate is supplied mainly by chemical and pharmaceutical ingredient producers with niche focus on specialty copper compounds. Buyers should prioritize GMP compliance, product certifications, and supplier reliability. Major suppliers include Thermo Fisher Scientific, Spectrum Chemical, Alfa Aesar, Toronto Research Chemicals, and Hangzhou J&K Chemical. Custom synthesis options are available for research and pharma-grade applications.


FAQs

1. Can I source pharmaceutical-grade Copper Histidinate for clinical use?
Yes. Suppliers with GMP certification and proper regulatory documentation, such as Thermo Fisher Scientific or Alfa Aesar, can provide pharmaceutical-grade Copper Histidinate suitable for clinical applications.

2. What purity standards should I look for?
Pharmaceutical-grade Copper Histidinate should meet USP, EP, or equivalent standards, indicating high purity and quality control compliance.

3. Are there regional differences in supplier availability?
Yes. North American and European suppliers often have more GMP-certified options, while China provides research-grade compounds at lower cost, but with variable quality standards.

4. Is custom synthesis necessary for small quantities?
Custom synthesis is often required for quantities below commercial bulk levels, especially for high-purity or specific salt forms.

5. What are typical lead times for sourcing Copper Histidinate?
Standard orders from research-grade suppliers may take 1-3 weeks, while GMP-compliant manufacturing can take 4-8 weeks depending on complexity and certification requirements.


References

  1. U.S. Food and Drug Administration. (2022). Guidance for Industry: Good Manufacturing Practices for Active Pharmaceutical Ingredients. Retrieved from https://www.fda.gov
  2. European Pharmacopoeia. (2022). Copper salts specifications.
  3. Pharmaceutical supplier websites and product datasheets, 2023.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.